1. Home
  2. LUCD vs GECC Comparison

LUCD vs GECC Comparison

Compare LUCD & GECC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LUCD
  • GECC
  • Stock Information
  • Founded
  • LUCD 2018
  • GECC 2016
  • Country
  • LUCD United States
  • GECC United States
  • Employees
  • LUCD N/A
  • GECC N/A
  • Industry
  • LUCD Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • GECC Finance: Consumer Services
  • Sector
  • LUCD Health Care
  • GECC Finance
  • Exchange
  • LUCD Nasdaq
  • GECC Nasdaq
  • Market Cap
  • LUCD 135.6M
  • GECC 122.4M
  • IPO Year
  • LUCD 2021
  • GECC N/A
  • Fundamental
  • Price
  • LUCD $1.25
  • GECC $10.60
  • Analyst Decision
  • LUCD Strong Buy
  • GECC
  • Analyst Count
  • LUCD 4
  • GECC 0
  • Target Price
  • LUCD $3.88
  • GECC N/A
  • AVG Volume (30 Days)
  • LUCD 1.1M
  • GECC 22.6K
  • Earning Date
  • LUCD 05-14-2025
  • GECC 05-05-2025
  • Dividend Yield
  • LUCD N/A
  • GECC 14.19%
  • EPS Growth
  • LUCD N/A
  • GECC N/A
  • EPS
  • LUCD N/A
  • GECC 0.42
  • Revenue
  • LUCD $4,173,000.00
  • GECC $42,909,000.00
  • Revenue This Year
  • LUCD $98.50
  • GECC $33.52
  • Revenue Next Year
  • LUCD $208.02
  • GECC N/A
  • P/E Ratio
  • LUCD N/A
  • GECC $25.16
  • Revenue Growth
  • LUCD 39.89
  • GECC 18.13
  • 52 Week Low
  • LUCD $0.68
  • GECC $8.87
  • 52 Week High
  • LUCD $1.80
  • GECC $11.39
  • Technical
  • Relative Strength Index (RSI)
  • LUCD 44.52
  • GECC 55.53
  • Support Level
  • LUCD $1.21
  • GECC $10.29
  • Resistance Level
  • LUCD $1.70
  • GECC $10.70
  • Average True Range (ATR)
  • LUCD 0.12
  • GECC 0.18
  • MACD
  • LUCD 0.01
  • GECC -0.02
  • Stochastic Oscillator
  • LUCD 27.42
  • GECC 74.70

About LUCD Lucid Diagnostics Inc.

Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.

About GECC Great Elm Capital Corp.

Great Elm Capital Corp is an externally managed, non-diversified closed-end management investment company. It generate both income and capital appreciation through debt and income-generating equity investments, including investments in finance businesses.

Share on Social Networks: